InvestorsHub Logo
Followers 1
Posts 160
Boards Moderated 0
Alias Born 10/17/2013

Re: None

Tuesday, 12/03/2013 3:49:00 PM

Tuesday, December 03, 2013 3:49:00 PM

Post# of 429300
Pretty interesting that a Forbes contributor, Larry Husten, has this to say the day that the SPA was rescinded, "But if Amarin does abandon the trial, is there an alternative? Some cholesterol experts I’ve spoken with believe the NHLBI should pick up the trial if it is abandoned"

Experts already talking about the government picking up Reduce-It. Must be an important study. Was this the plan all along?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News